- Home
- GROW vs PMN Comparison
GROW vs PMN Comparison
Compare GROW & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROW
- PMN
- Stock Information
- Founded
- GROW 1968
- PMN 2004
- Country
- GROW United States
- PMN Canada
- Employees
- GROW N/A
- PMN N/A
- Industry
- GROW Investment Managers
- PMN Pharmaceuticals and Biotechnology
- Sector
- GROW Finance
- PMN Health Care
- Exchange
- GROW Nasdaq
- PMN Nasdaq
- Market Cap
- GROW 31.8M
- PMN 16.0M
- IPO Year
- GROW N/A
- PMN N/A
- Fundamental
- Price
- GROW $2.41
- PMN $0.52
- Analyst Decision
- GROW
- PMN Strong Buy
- Analyst Count
- GROW 0
- PMN 3
- Target Price
- GROW N/A
- PMN $4.33
- AVG Volume (30 Days)
- GROW 44.9K
- PMN 4.8M
- Earning Date
- GROW 09-09-2025
- PMN 08-07-2025
- Dividend Yield
- GROW 3.72%
- PMN N/A
- EPS Growth
- GROW N/A
- PMN N/A
- EPS
- GROW 0.01
- PMN N/A
- Revenue
- GROW $8,932,000.00
- PMN N/A
- Revenue This Year
- GROW N/A
- PMN N/A
- Revenue Next Year
- GROW N/A
- PMN N/A
- P/E Ratio
- GROW $232.40
- PMN N/A
- Revenue Growth
- GROW N/A
- PMN N/A
- 52 Week Low
- GROW $2.02
- PMN $0.38
- 52 Week High
- GROW $2.73
- PMN $2.22
- Technical
- Relative Strength Index (RSI)
- GROW 50.11
- PMN 58.75
- Support Level
- GROW $2.38
- PMN $0.48
- Resistance Level
- GROW $2.49
- PMN $0.43
- Average True Range (ATR)
- GROW 0.09
- PMN 0.09
- MACD
- GROW -0.01
- PMN 0.00
- Stochastic Oscillator
- GROW 18.18
- PMN 16.09
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.